ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Measles and Rubella (MR) Vaccine Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-29P10761
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Measles and Rubella MR Vaccine Market Research Report 2022
BUY CHAPTERS

Global Measles and Rubella (MR) Vaccine Market Research Report 2025

Code: QYRE-Auto-29P10761
Report
January 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
PT Bio Farma
Bio-Manguinhos
BE Vaccines
Crucell Switzerland AG

Measles and Rubella (MR) Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Measles and Rubella (MR) Vaccine Market

Measles and Rubella (MR) Vaccine Market

The global market for Measles and Rubella (MR) Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Measles and Rubella (MR) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles and Rubella (MR) Vaccine.
The Measles and Rubella (MR) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Measles and Rubella (MR) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Measles and Rubella (MR) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Measles and Rubella (MR) Vaccine Market Report

Report Metric Details
Report Name Measles and Rubella (MR) Vaccine Market
CAGR 5%
Segment by Type
  • MR Vaccine
  • MRBEV Vaccine
Segment by Application
  • Private Distribution Channel
  • Public Distribution Channel
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company PT Bio Farma, Bio-Manguinhos, BE Vaccines, Crucell Switzerland AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Measles and Rubella (MR) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Measles and Rubella (MR) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Measles and Rubella (MR) Vaccine Market report?

Ans: The main players in the Measles and Rubella (MR) Vaccine Market are PT Bio Farma, Bio-Manguinhos, BE Vaccines, Crucell Switzerland AG

What are the Application segmentation covered in the Measles and Rubella (MR) Vaccine Market report?

Ans: The Applications covered in the Measles and Rubella (MR) Vaccine Market report are Private Distribution Channel, Public Distribution Channel

What are the Type segmentation covered in the Measles and Rubella (MR) Vaccine Market report?

Ans: The Types covered in the Measles and Rubella (MR) Vaccine Market report are MR Vaccine, MRBEV Vaccine

Recommended Reports

Vaccine Market

Vaccine Devices & Delivery

Other Infectious Vaccines

1 Measles and Rubella (MR) Vaccine Market Overview
1.1 Product Definition
1.2 Measles and Rubella (MR) Vaccine by Type
1.2.1 Global Measles and Rubella (MR) Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 MR Vaccine
1.2.3 MRBEV Vaccine
1.3 Measles and Rubella (MR) Vaccine by Application
1.3.1 Global Measles and Rubella (MR) Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Private Distribution Channel
1.3.3 Public Distribution Channel
1.4 Global Measles and Rubella (MR) Vaccine Market Size Estimates and Forecasts
1.4.1 Global Measles and Rubella (MR) Vaccine Revenue 2020-2031
1.4.2 Global Measles and Rubella (MR) Vaccine Sales 2020-2031
1.4.3 Global Measles and Rubella (MR) Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Measles and Rubella (MR) Vaccine Market Competition by Manufacturers
2.1 Global Measles and Rubella (MR) Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Measles and Rubella (MR) Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Measles and Rubella (MR) Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Measles and Rubella (MR) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Measles and Rubella (MR) Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measles and Rubella (MR) Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Measles and Rubella (MR) Vaccine, Date of Enter into This Industry
2.8 Global Measles and Rubella (MR) Vaccine Market Competitive Situation and Trends
2.8.1 Global Measles and Rubella (MR) Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Measles and Rubella (MR) Vaccine Players Market Share by Revenue
2.8.3 Global Measles and Rubella (MR) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Measles and Rubella (MR) Vaccine Market Scenario by Region
3.1 Global Measles and Rubella (MR) Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Measles and Rubella (MR) Vaccine Sales by Region: 2020-2031
3.2.1 Global Measles and Rubella (MR) Vaccine Sales by Region: 2020-2025
3.2.2 Global Measles and Rubella (MR) Vaccine Sales by Region: 2026-2031
3.3 Global Measles and Rubella (MR) Vaccine Revenue by Region: 2020-2031
3.3.1 Global Measles and Rubella (MR) Vaccine Revenue by Region: 2020-2025
3.3.2 Global Measles and Rubella (MR) Vaccine Revenue by Region: 2026-2031
3.4 North America Measles and Rubella (MR) Vaccine Market Facts & Figures by Country
3.4.1 North America Measles and Rubella (MR) Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Measles and Rubella (MR) Vaccine Sales by Country (2020-2031)
3.4.3 North America Measles and Rubella (MR) Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Measles and Rubella (MR) Vaccine Market Facts & Figures by Country
3.5.1 Europe Measles and Rubella (MR) Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Measles and Rubella (MR) Vaccine Sales by Country (2020-2031)
3.5.3 Europe Measles and Rubella (MR) Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measles and Rubella (MR) Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Measles and Rubella (MR) Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Measles and Rubella (MR) Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Measles and Rubella (MR) Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Measles and Rubella (MR) Vaccine Market Facts & Figures by Country
3.7.1 Latin America Measles and Rubella (MR) Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Measles and Rubella (MR) Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Measles and Rubella (MR) Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measles and Rubella (MR) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Measles and Rubella (MR) Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Measles and Rubella (MR) Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Measles and Rubella (MR) Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Measles and Rubella (MR) Vaccine Sales by Type (2020-2031)
4.1.1 Global Measles and Rubella (MR) Vaccine Sales by Type (2020-2025)
4.1.2 Global Measles and Rubella (MR) Vaccine Sales by Type (2026-2031)
4.1.3 Global Measles and Rubella (MR) Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Measles and Rubella (MR) Vaccine Revenue by Type (2020-2031)
4.2.1 Global Measles and Rubella (MR) Vaccine Revenue by Type (2020-2025)
4.2.2 Global Measles and Rubella (MR) Vaccine Revenue by Type (2026-2031)
4.2.3 Global Measles and Rubella (MR) Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Measles and Rubella (MR) Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Measles and Rubella (MR) Vaccine Sales by Application (2020-2031)
5.1.1 Global Measles and Rubella (MR) Vaccine Sales by Application (2020-2025)
5.1.2 Global Measles and Rubella (MR) Vaccine Sales by Application (2026-2031)
5.1.3 Global Measles and Rubella (MR) Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Measles and Rubella (MR) Vaccine Revenue by Application (2020-2031)
5.2.1 Global Measles and Rubella (MR) Vaccine Revenue by Application (2020-2025)
5.2.2 Global Measles and Rubella (MR) Vaccine Revenue by Application (2026-2031)
5.2.3 Global Measles and Rubella (MR) Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Measles and Rubella (MR) Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 PT Bio Farma
6.1.1 PT Bio Farma Company Information
6.1.2 PT Bio Farma Description and Business Overview
6.1.3 PT Bio Farma Measles and Rubella (MR) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 PT Bio Farma Measles and Rubella (MR) Vaccine Product Portfolio
6.1.5 PT Bio Farma Recent Developments/Updates
6.2 Bio-Manguinhos
6.2.1 Bio-Manguinhos Company Information
6.2.2 Bio-Manguinhos Description and Business Overview
6.2.3 Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Manguinhos Measles and Rubella (MR) Vaccine Product Portfolio
6.2.5 Bio-Manguinhos Recent Developments/Updates
6.3 BE Vaccines
6.3.1 BE Vaccines Company Information
6.3.2 BE Vaccines Description and Business Overview
6.3.3 BE Vaccines Measles and Rubella (MR) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BE Vaccines Measles and Rubella (MR) Vaccine Product Portfolio
6.3.5 BE Vaccines Recent Developments/Updates
6.4 Crucell Switzerland AG
6.4.1 Crucell Switzerland AG Company Information
6.4.2 Crucell Switzerland AG Description and Business Overview
6.4.3 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Product Portfolio
6.4.5 Crucell Switzerland AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measles and Rubella (MR) Vaccine Industry Chain Analysis
7.2 Measles and Rubella (MR) Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measles and Rubella (MR) Vaccine Production Mode & Process Analysis
7.4 Measles and Rubella (MR) Vaccine Sales and Marketing
7.4.1 Measles and Rubella (MR) Vaccine Sales Channels
7.4.2 Measles and Rubella (MR) Vaccine Distributors
7.5 Measles and Rubella (MR) Vaccine Customer Analysis
8 Measles and Rubella (MR) Vaccine Market Dynamics
8.1 Measles and Rubella (MR) Vaccine Industry Trends
8.2 Measles and Rubella (MR) Vaccine Market Drivers
8.3 Measles and Rubella (MR) Vaccine Market Challenges
8.4 Measles and Rubella (MR) Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
PT Bio Farma
Bio-Manguinhos
BE Vaccines
Crucell Switzerland AG
List of Tables
 Table 1. Global Measles and Rubella (MR) Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Measles and Rubella (MR) Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Measles and Rubella (MR) Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Measles and Rubella (MR) Vaccine Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Measles and Rubella (MR) Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Measles and Rubella (MR) Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Measles and Rubella (MR) Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Measles and Rubella (MR) Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Measles and Rubella (MR) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Measles and Rubella (MR) Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Measles and Rubella (MR) Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Measles and Rubella (MR) Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Measles and Rubella (MR) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles and Rubella (MR) Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Measles and Rubella (MR) Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Measles and Rubella (MR) Vaccine Sales by Region (2020-2025) & (Units)
 Table 18. Global Measles and Rubella (MR) Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Measles and Rubella (MR) Vaccine Sales by Region (2026-2031) & (Units)
 Table 20. Global Measles and Rubella (MR) Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Measles and Rubella (MR) Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Measles and Rubella (MR) Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Measles and Rubella (MR) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Measles and Rubella (MR) Vaccine Sales by Country (2020-2025) & (Units)
 Table 27. North America Measles and Rubella (MR) Vaccine Sales by Country (2026-2031) & (Units)
 Table 28. North America Measles and Rubella (MR) Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Measles and Rubella (MR) Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Measles and Rubella (MR) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Measles and Rubella (MR) Vaccine Sales by Country (2020-2025) & (Units)
 Table 32. Europe Measles and Rubella (MR) Vaccine Sales by Country (2026-2031) & (Units)
 Table 33. Europe Measles and Rubella (MR) Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Measles and Rubella (MR) Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Measles and Rubella (MR) Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Measles and Rubella (MR) Vaccine Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Measles and Rubella (MR) Vaccine Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Measles and Rubella (MR) Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Measles and Rubella (MR) Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Measles and Rubella (MR) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Measles and Rubella (MR) Vaccine Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Measles and Rubella (MR) Vaccine Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Measles and Rubella (MR) Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Measles and Rubella (MR) Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Measles and Rubella (MR) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Measles and Rubella (MR) Vaccine Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Measles and Rubella (MR) Vaccine Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Measles and Rubella (MR) Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Measles and Rubella (MR) Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Measles and Rubella (MR) Vaccine Sales (Units) by Type (2020-2025)
 Table 51. Global Measles and Rubella (MR) Vaccine Sales (Units) by Type (2026-2031)
 Table 52. Global Measles and Rubella (MR) Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Measles and Rubella (MR) Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Measles and Rubella (MR) Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Measles and Rubella (MR) Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Measles and Rubella (MR) Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Measles and Rubella (MR) Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Measles and Rubella (MR) Vaccine Sales (Units) by Application (2020-2025)
 Table 61. Global Measles and Rubella (MR) Vaccine Sales (Units) by Application (2026-2031)
 Table 62. Global Measles and Rubella (MR) Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Measles and Rubella (MR) Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Measles and Rubella (MR) Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Measles and Rubella (MR) Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Measles and Rubella (MR) Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Measles and Rubella (MR) Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. PT Bio Farma Company Information
 Table 71. PT Bio Farma Description and Business Overview
 Table 72. PT Bio Farma Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. PT Bio Farma Measles and Rubella (MR) Vaccine Product
 Table 74. PT Bio Farma Recent Developments/Updates
 Table 75. Bio-Manguinhos Company Information
 Table 76. Bio-Manguinhos Description and Business Overview
 Table 77. Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bio-Manguinhos Measles and Rubella (MR) Vaccine Product
 Table 79. Bio-Manguinhos Recent Developments/Updates
 Table 80. BE Vaccines Company Information
 Table 81. BE Vaccines Description and Business Overview
 Table 82. BE Vaccines Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BE Vaccines Measles and Rubella (MR) Vaccine Product
 Table 84. BE Vaccines Recent Developments/Updates
 Table 85. Crucell Switzerland AG Company Information
 Table 86. Crucell Switzerland AG Description and Business Overview
 Table 87. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Product
 Table 89. Crucell Switzerland AG Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Measles and Rubella (MR) Vaccine Distributors List
 Table 93. Measles and Rubella (MR) Vaccine Customers List
 Table 94. Measles and Rubella (MR) Vaccine Market Trends
 Table 95. Measles and Rubella (MR) Vaccine Market Drivers
 Table 96. Measles and Rubella (MR) Vaccine Market Challenges
 Table 97. Measles and Rubella (MR) Vaccine Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Measles and Rubella (MR) Vaccine
 Figure 2. Global Measles and Rubella (MR) Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Measles and Rubella (MR) Vaccine Market Share by Type: 2024 & 2031
 Figure 4. MR Vaccine Product Picture
 Figure 5. MRBEV Vaccine Product Picture
 Figure 6. Global Measles and Rubella (MR) Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Measles and Rubella (MR) Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Private Distribution Channel
 Figure 9. Public Distribution Channel
 Figure 10. Global Measles and Rubella (MR) Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Measles and Rubella (MR) Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Measles and Rubella (MR) Vaccine Sales (2020-2031) & (Units)
 Figure 13. Global Measles and Rubella (MR) Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Measles and Rubella (MR) Vaccine Report Years Considered
 Figure 15. Measles and Rubella (MR) Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Measles and Rubella (MR) Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Measles and Rubella (MR) Vaccine Players: Market Share by Revenue in Measles and Rubella (MR) Vaccine in 2024
 Figure 18. Measles and Rubella (MR) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Measles and Rubella (MR) Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Measles and Rubella (MR) Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Measles and Rubella (MR) Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Measles and Rubella (MR) Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Measles and Rubella (MR) Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Measles and Rubella (MR) Vaccine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Measles and Rubella (MR) Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Measles and Rubella (MR) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Measles and Rubella (MR) Vaccine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Measles and Rubella (MR) Vaccine by Type (2020-2031)
 Figure 54. Global Measles and Rubella (MR) Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Measles and Rubella (MR) Vaccine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Measles and Rubella (MR) Vaccine by Application (2020-2031)
 Figure 57. Global Measles and Rubella (MR) Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Measles and Rubella (MR) Vaccine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Measles and Rubella Vaccines Market Research Report 2025
Measles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Attenuated Measles Vaccine Market Research Report 2025
Global Measles Combined with Live Attenuated Vaccine Market Research Report 2025
Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Vaccine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Attenuated Vaccine Market Research Report 2025
Global Viral Vaccines Market Research Report 2025
Paediatric Vaccine Market
Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Tuberculosis Vaccine Market Research Report 2025
Global Measles and Rubella Vaccine Market Research Report 2025
Respiratory Syncytial Virus Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Digital Data Logger Market Insights Forecast to 2030
Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Cooler Market Research Report 2025
Aluminum based Vaccine Adjuvant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GP Vaccination Market Research Report 2025
Global Influenza Drugs and Vaccines Market Research Report 2025
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions